Sanofi

News

Sanofi, GSK claim their first COVID jab approval

For all their long history in vaccines, GSK and Sanofi have struggled to get a shot for COVID-19 authorised – but they have finally crossed the finish line in Europe.

News

Former Sanofi head Viehbacher to become Biogen CEO

Six months after Biogen began its search for new leadership, the biotech has now named former Sanofi chief executive

News

Sanofi signs $1.2bn research alliance with AI specialist Ins...

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 billion.

News

AZ, Sanofi get first green light for RSV prophylactic antibo...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections.<

News

Radiology technician examens mammography test on location

After setbacks for Roche and Sanofi, AZ scores oral SERD win

AstraZeneca seems to have dodged the problems besetting other developers of oral selective oestrogen receptor degrader (SERD) drugs with a phase 2 win for its candidate camizestrant in a ph

News

Weak data for Fasenra undermine AZ's ambitions for the drug

AstraZeneca's IL-5 inhibitor Fasenra is already making blockbuster sales from its use in eosinophilic asthma, but the drugmaker's efforts to expand its label keep running into difficulties.

Sanofi, GSK claim their first COVID jab approval

Former Sanofi head Viehbacher to become Biogen CEO

Sanofi signs $1.2bn research alliance with AI specialist Ins...

AZ, Sanofi get first green light for RSV prophylactic antibo...

After setbacks for Roche and Sanofi, AZ scores oral SERD win

Weak data for Fasenra undermine AZ's ambitions for the drug

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Sanofi

Editor's Picks